126 related articles for article (PubMed ID: 26434819)
1. Tumor-Suppression Mechanisms of Protein Tyrosine Phosphatase O and Clinical Applications.
Kang MM; Shan SL; Wen XY; Shan HS; Wang ZJ
Asian Pac J Cancer Prev; 2015; 16(15):6215-23. PubMed ID: 26434819
[TBL] [Abstract][Full Text] [Related]
2. Protein Tyrosine Phosphatase Receptor Type J (PTPRJ) Regulates Retinal Axonal Projections by Inhibiting Eph and Abl Kinases in Mice.
Yu Y; Shintani T; Takeuchi Y; Shirasawa T; Noda M
J Neurosci; 2018 Sep; 38(39):8345-8363. PubMed ID: 30082414
[TBL] [Abstract][Full Text] [Related]
3. The tyrosine phosphatase PTPRO sensitizes colon cancer cells to anti-EGFR therapy through activation of SRC-mediated EGFR signaling.
Asbagh LA; Vazquez I; Vecchione L; Budinska E; De Vriendt V; Baietti MF; Steklov M; Jacobs B; Hoe N; Singh S; Imjeti NS; Zimmermann P; Sablina A; Tejpar S
Oncotarget; 2014 Oct; 5(20):10070-83. PubMed ID: 25301722
[TBL] [Abstract][Full Text] [Related]
4. Estrogen-sensitive PTPRO expression represses hepatocellular carcinoma progression by control of STAT3.
Hou J; Xu J; Jiang R; Wang Y; Chen C; Deng L; Huang X; Wang X; Sun B
Hepatology; 2013 Feb; 57(2):678-88. PubMed ID: 22821478
[TBL] [Abstract][Full Text] [Related]
5. Expression profiling during mammary epithelial cell three-dimensional morphogenesis identifies PTPRO as a novel regulator of morphogenesis and ErbB2-mediated transformation.
Yu M; Lin G; Arshadi N; Kalatskaya I; Xue B; Haider S; Nguyen F; Boutros PC; Elson A; Muthuswamy LB; Tonks NK; Muthuswamy SK
Mol Cell Biol; 2012 Oct; 32(19):3913-24. PubMed ID: 22851698
[TBL] [Abstract][Full Text] [Related]
6. Eph receptors are negatively controlled by protein tyrosine phosphatase receptor type O.
Shintani T; Ihara M; Sakuta H; Takahashi H; Watakabe I; Noda M
Nat Neurosci; 2006 Jun; 9(6):761-9. PubMed ID: 16680165
[TBL] [Abstract][Full Text] [Related]
7. PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism.
Dai W; Xiang W; Han L; Yuan Z; Wang R; Ma Y; Yang Y; Cai S; Xu Y; Mo S; Li Q; Cai G
Cancer Commun (Lond); 2022 Sep; 42(9):848-867. PubMed ID: 35904817
[TBL] [Abstract][Full Text] [Related]
8. Protein tyrosine phosphatase PTPRO represses lung adenocarcinoma progression by inducing mitochondria-dependent apoptosis and restraining tumor metastasis.
Dai Y; Shi S; Liu H; Zhou H; Ding W; Liu C; Jin L; Xie W; Kong H; Zhang Q
Cell Death Dis; 2024 Jan; 15(1):11. PubMed ID: 38182570
[TBL] [Abstract][Full Text] [Related]
9. PTPRO plays a dual role in hepatic ischemia reperfusion injury through feedback activation of NF-κB.
Hou J; Xia Y; Jiang R; Chen D; Xu J; Deng L; Huang X; Wang X; Sun B
J Hepatol; 2014 Feb; 60(2):306-12. PubMed ID: 24128416
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine phosphorylation of R3 subtype receptor-type protein tyrosine phosphatases and their complex formations with Grb2 or Fyn.
Murata Y; Mori M; Kotani T; Supriatna Y; Okazawa H; Kusakari S; Saito Y; Ohnishi H; Matozaki T
Genes Cells; 2010 May; 15(5):513-24. PubMed ID: 20398064
[TBL] [Abstract][Full Text] [Related]
11. Epigenetically silenced PTPRO functions as a prognostic marker and tumor suppressor in human lung squamous cell carcinoma.
Ming F; Sun Q
Mol Med Rep; 2017 Jul; 16(1):746-754. PubMed ID: 28586036
[TBL] [Abstract][Full Text] [Related]
12. PTPRO-associated hepatic stellate cell activation plays a critical role in liver fibrosis.
Zhang X; Tan Z; Wang Y; Tang J; Jiang R; Hou J; Zhuo H; Wang X; Ji J; Qin X; Sun B
Cell Physiol Biochem; 2015; 35(3):885-98. PubMed ID: 25633279
[TBL] [Abstract][Full Text] [Related]
13. Methylation of the PTPRO gene in human hepatocellular carcinoma and identification of VCP as its substrate.
Hsu SH; Motiwala T; Roy S; Claus R; Mustafa M; Plass C; Freitas MA; Ghoshal K; Jacob ST
J Cell Biochem; 2013 Aug; 114(8):1810-8. PubMed ID: 23533167
[TBL] [Abstract][Full Text] [Related]
14. PTPRO represses ERBB2-driven breast oncogenesis by dephosphorylation and endosomal internalization of ERBB2.
Dong H; Ma L; Gan J; Lin W; Chen C; Yao Z; Du L; Zheng L; Ke C; Huang X; Song H; Kumar R; Yeung SC; Zhang H
Oncogene; 2017 Jan; 36(3):410-422. PubMed ID: 27345410
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine phosphatases as a superfamily of tumor suppressors in colorectal cancer.
Laczmanska I; Sasiadek MM
Acta Biochim Pol; 2011; 58(4):467-70. PubMed ID: 22146137
[TBL] [Abstract][Full Text] [Related]
16. Protein tyrosine phosphatase receptor-type O (PTPRO) is co-regulated by E2F1 and miR-17-92.
Xu X; Hong Y; Kong C; Xu L; Tan J; Liang Q; Huang B; Lu J
FEBS Lett; 2008 Aug; 582(19):2850-6. PubMed ID: 18644370
[TBL] [Abstract][Full Text] [Related]
17. Identification of ptpro as a novel target gene of Wnt signaling and its potential role as a receptor for Wnt.
Kim M; Kim H; Jho EH
FEBS Lett; 2010 Sep; 584(18):3923-8. PubMed ID: 20804755
[TBL] [Abstract][Full Text] [Related]
18. Protein tyrosine phosphatase receptor type O inhibits trigeminal axon growth and branching by repressing TrkB and Ret signaling.
Gatto G; Dudanova I; Suetterlin P; Davies AM; Drescher U; Bixby JL; Klein R
J Neurosci; 2013 Mar; 33(12):5399-410. PubMed ID: 23516305
[TBL] [Abstract][Full Text] [Related]
19. Regulatory Functions of Protein Tyrosine Phosphatase Receptor Type O in Immune Cells.
Xie F; Dong H; Zhang H
Front Immunol; 2021; 12():783370. PubMed ID: 34880876
[TBL] [Abstract][Full Text] [Related]
20. Stepping out of the shadows: Oncogenic and tumor-promoting protein tyrosine phosphatases.
Elson A
Int J Biochem Cell Biol; 2018 Mar; 96():135-147. PubMed ID: 28941747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
